Novelta Pharmaceuticals Inc - Houston, Texas 77027

Novelta Pharmaceuticals Inc is categorized under Unclassified in Houston, TX .

Business Name: Novelta Pharmaceuticals Inc
Contact Person: Peter H Proctor
Address: 4518 Oakshire Drive, Houston, Texas 77027
Phone Number: (713) 552-0782
Annual Revenue (USD): $50.000 to $99.999
Founding Year: 2007
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Unclassified
SIC Code: 7389
NAICS Code: 561990
Share This Business:
Related Businesses: Sam Chambers - Houston, TX 77027
Art Abundance - Houston, TX 77027
Juno Labs Inc - Houston, TX 77027
Gene Thomas - Houston, TX 77027
Edward Grady - Houston, TX 77027
Stahi Company - Houston, TX 77027
Marcioni Inc - Houston, TX 77027
Brent Michael Cordell P C - Houston, TX 77027
J P Bohn & Company - Houston, TX 77027
William H The Wallace - Houston, TX 77027
Oldham Inc - Houston, TX 77027
Tghsll Inc - Houston, TX 77027
Jacks Lazy Inc - Houston, TX 77027
Sabr LLC - Houston, TX 77027
In Lieu Of LLC - Houston, TX 77027
River Trace Lp - Houston, TX 77027
Forensic Education Project - Houston, TX 77027
Girls Gotta Have Pearls - Houston, TX 77027
Eastland Interests Ltd - Houston, TX 77027
Thomas Scott Elise Smith - Houston, TX 77027

The company Novelta Pharmaceuticals Inc provides B2B services in the form of Unclassified from its single location in Texas. 1 to 4 employees work for Novelta Pharmaceuticals Inc, and the business now earns $50.000 to $99.999 per annum.

Novelta Pharmaceuticals Inc was launched in 2007 and is classified under SIC code and category 7389 , and NAICS number and grouping 561990 . To contact Novelta Pharmaceuticals Inc, please call Peter H Proctor with the phone number (713) 552-0782 or visit its single location at 4518 Oakshire Drive in Houston, Texas 77027.

The location of the single location can also be found using the coordinates 29.737453,-95.452182. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.